StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.13+0.00 (0.00%)

Close on Nov 18, 2026Market cap $3.26BP/E –Yield –

BGM revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $37.92M, up 51.1% from the year before. The highest annual figure on record is $64.86M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$37.92M+51.1%
FY2024Sep 30, 2024$25.10M-46.0%
FY2023Sep 30, 2023$46.47M-28.3%
FY2022Sep 30, 2022$64.86M+13.6%
FY2021Sep 30, 2021$57.10M+14.1%
FY2020Sep 30, 2020$50.03M+8.5%
FY2019Sep 30, 2019$46.10M-8.5%
FY2018Sep 30, 2018$50.37M–

More BGM figures

See a number that looks wrong?